5341.KLSE LACMED
- Market cap
- MYR 266M
- P/E
- 13.5x
- P/B
- 2.24x
- ROE
- 10.3%
- Dividend yield
- 1.88%
- Fundamental score
- 2.7/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 5341.KLSE undervalued?
Graham number5341.KLSE trades 15.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
LACMED fundamental analysis
13 of 22 checks passedROE 1/2
Moderate return on equity (10.3%), between 10% and 20%.
ROA 1/1
Return on assets (5.5%) is above the industry median (-7.4%).
Profit Consistency 1/2
Profitable for 4 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (7.5%) is above the industry median (5.2%).
Revenue Growth 2/2
Revenue grew 23.7% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (0.8%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 1/1
EBIT is 20.0x against interest expense, well covered.
PE vs Market 0/1
PE (13.3x) is above the market median (11.4x).
PE vs Industry 1/1
PE (13.3x) is below the industry median (19.0x).
PBV 1/1
Price to book (2.2x) is below the industry median (2.5x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 29.3, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 1/2
Dividend yield (1.9%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 22.8%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About LACMED
LAC Med Berhad engages in the distribution, supply, and integration of medical devices, diagnostic equipment, and digital health solutions for diagnostic purposes in Malaysia and Indonesia. The company offers diagnostic equipment, radiographic, ultrasound, magnetic resonance imaging (MRI), as well as software systems and maintenance services. It serves hospitals, clinics, and healthcare providers. The company was incorporated in 2003 and is headquartered in Petaling Jaya, Ma…
Full company profileLACMED financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
LACMED annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 107M | 150M | 183M | 202M | 150M |
| Gross Profit | 29.8M | 41.0M | 45.5M | 58.5M | 39.4M |
| Operating Income | 19.7M | 24.5M | 27.6M | 31.5M | 16.1M |
| EBITDA | 18.2M | 27.0M | 27.9M | 32.9M | 21.0M |
| Net Income | 13.1M | 20.7M | 20.4M | 21.9M | 12.6M |
| EPS | 0.03 | 0.05 | 0.05 | 0.05 | 0.03 |
| Balance Sheet | |||||
| Total Assets | 103M | 140M | 128M | 236M | 228M |
| Total Liabilities | 78.1M | 99.7M | 80.2M | 117M | 106M |
| Shareholders' Equity | 25.1M | 39.9M | 47.8M | 119M | 122M |
| Cash & Short-term Investments | 23.8M | 30.5M | 15.8M | 64.9M | 40.0M |
| Cash Flow | |||||
| Operating Cash Flow | 2.87M | 22.6M | 30.7M | 589K | -47.9M |
| Capital Expenditure | 227K | 894K | 501K | 12.2M | 7.98M |
| Free Cash Flow | 2.65M | 21.7M | 30.2M | -11.6M | -55.8M |
| Ratios | |||||
| ROE | 52.0% | 52.0% | 42.7% | 18.5% | 10.3% |
| ROA | 12.7% | 14.9% | 15.9% | 9.3% | 5.5% |
| Net Profit Margin | 12.3% | 13.8% | 11.1% | 10.9% | 8.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
LACMED dividends
- Dividend yield
- 1.88%
- Forward dividend
- 0.01 MYR
- Payout ratio
- 22.8%
- Ex-dividend date
- May 26, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | MYR 5.00M | 0.01 | 22.8% |
| 2024 | MYR 18.5M | 0.05 | 90.7% |
| 2023 | MYR 4.00M | 0.01 | 19.3% |
| 2022 | MYR 3.40M | 0.01 | 26.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns LACMED
- Insiders 80.79%
- Institutions 6.88%
- Public & others 12.33%
- Shares outstanding 400M
- Free float 88.2M
LACMED company profile
- Company name
- LACMED
- Ticker
- 5341.KLSE
- Exchange
- Kuala Lumpur Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 100
- Fiscal year end
- December
- Address
- G-03A-3, Plaza Kelana Jaya, Petaling Jaya, Malaysia, 47301
- Phone
- 60 3 7800 9064
- Website
- lacmed.com
About LACMED
LAC Med Berhad engages in the distribution, supply, and integration of medical devices, diagnostic equipment, and digital health solutions for diagnostic purposes in Malaysia and Indonesia. The company offers diagnostic equipment, radiographic, ultrasound, magnetic resonance imaging (MRI), as well as software systems and maintenance services. It serves hospitals, clinics, and healthcare providers. The company was incorporated in 2003 and is headquartered in Petaling Jaya, Malaysia.
LACMED management
7- Mr. Yoon Poh LiewGroup CEO & Executive Director · born 1981
- Mr. Chong Chet HongDeputy Chief Executive Officer · born 1981
- Ms. Yain Peng TheanChief Financial Officer · born 1968
- Ms. Mei Peng ChooChief People Officer · born 1966
- Mr. Sheau San SumSenior Vice President of Service Operations · born 1977
- Mr. Peng Ting TehChief Commercial Officer · born 1980
- Sze Ren OngCompany Secretary